Medications Flashcards
Classes of medications used in psychiatry
ANTIPSYCHOTICS: TYPICAL 1ST GENERATION, ATYPICAL 2ND GENERATION , 3RD GENERATION; SSRI’S; SNRI’S; NDM’S; MOOD STABILIZERS; ANTIANXIETY AGENTS; ANTIPARKINSONIAN DRUGS
ANTIPSYCHOTICS TYPICAL (1ST GENERATION)
FLUPENTHIXOL DECANOATE (FLUANXOL), HALOPERIDOL DECANOATE (HALDOL LA), FLUPHENAZINE (MODECATE), ZUCLOPENTHIXOL (CLOPIXOL), ZUCLOPENTHIXOL ACETATE (CLOPIXOL ACCUPHASE)
ATYPICAL 2ND GENERATION ANTIPSYCHOTICS
CLOZAPINE (CLOZARIL), OLANZAPINE (ZYPREXA), QUETIAPINE (SEROQUEL), RISPERDAL (INCLUDE CONSTA INJECTABLE FORM), PALIPERIDONE (INVEGA SUSTENNA), ARIPIPRAZOLE (ABILIFY)
3RD GENERATION
.
SSRIs
CITALOPRAM (CELEXA), ESCITALOPRAM (LEXAPRO), FLUOXETINE (PROZAC), FLUVOXAMINE (LUVOX), SERTRALINE (ZOLOFT)
SNRIs
VENLAFAXINE XR (EFFEXOR), ATOMOXETINE (STRATTERA)
NDMs
WELLBUTRIN (BRUPROPION)
Mood Stabilizers
LITHIUM, CARBAMAZEPINE (TEGRETOL), DEVALPROEX SODIUM (EPIVAL), VALPROIC ACID (DEPAKENE), GABAPENTIN (NEURONTIN), LAMOTRIGINE (LAMICTAL), CLONAZEPAM (RIVOTRIL)
Antianxiety agents
LORAZEPAM (ATIVAN), ALPRAZOLAM (XANAX), OXAZEPAM (SERAX), TEMAZEPAM (RESTORIL), ZOPLICONE (IMOVANE)
ANTIPARKINSONIAN DRUGS
BENZTROPINE (COGENTIN), PROCYCLIDENE (KEMADRIN), TRIHEXPHENIDYL (ARTANE)
Extra-pyramidal Symptoms (EPS)
Movement disorders that occur when there is a disruption of the brain’s extra-pyramidal system, can be caused by anti-psychotic agents (both 1st, and, to a lesser extent, by 2nd generation agents)
PARKINSONISM
tremor and muscle rigidity, also extreme slowness of movements
AKINESIA
also known as “bradykinesia” mean slowing down of movement, person may appear listless or lifeless or the face loose usual range of expression
ACUTE DYSTONIA
sudden muscular contractions, often produces neck or jaw spasms or causes eye to roll, severe EPS signs
ACUTE AKATHESIA
motor restlessness, inability to resist urge to move, pacing and inability to sit still common
TARDIVE DYSKINESIA
spasmodic involuntary movements, writhing like movements are common in face, mouth, tongue hands, assess using Abnormal Involuntary Movement Scale (AIMS), severe EPS signs
NEUROLEPTIC MALIGNANT SYNDROME (NMS)
Dopamine receptor blockade: Increased body temperature >38°C (>100.4°F), or Confused or altered consciousness, Diaphoresis “sweat shock”, Rigid musclesAutonomic imbalance
ABNORMAL INVOLUNTARY MO (AIMS) AND SIMPSON- ANGUS SCALE
designed to measure signs/symptoms of TD, monitoring the effects of long-term medication consumption; given every three to six months to monitor the patient for the development of TD; measure progression of TD; most patients, TD develops three months after the initiation of neuroleptic therapy
MENTAL HEALTH ACT
.
PERSONAL SAFETY ISSUES
.
Link the following signs and symptoms to the associated side-effect of antipsychotics
.
Loss of energy
Akinesia: slowing of movements, person may appear listless or lifeless with a restricted range of emotion expressed in the face (phsyical aspecti)
Feeling unmotivated or numb
Akinesia: the person complains of “feeling like zombie” or “slowed down” (internal aspect of akinesia)
Daytime sedation or drowsiness
Sedation: Common side-effect